Breast cancer trial with erythropoietin terminated unexpectedly
Top Cited Papers
- 1 August 2003
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (8) , 459-460
- https://doi.org/10.1016/s1470-2045(03)01163-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynxInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled TrialJournal of Clinical Oncology, 2001
- Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III studyEuropean Journal Of Cancer, 2001
- The importance of hemoglobin levels during radiotherapy for carcinoma of the cervixCancer, 1999
- Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen EffectGynecologic Oncology, 1999
- Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemiaBritish Journal of Cancer, 1998